Hyderabad

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has over 9,500 employees.

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Andhra Pradesh is one of the leading seed producing States in the country, comprising seven (7) distinct agro-climatic zones. The extensive network of seed growers all across the state, with a rich tradition of seed production and varietal improvements has enabled a strong core production of crops at comparatively lower costs with higher yields per unit.

GVK is a diversified enterprise having interests in Infrastructure (Power, Transportation and Urban Infrastructure), Services (Hotels, Life-sciences and Financial) and Manufacturing (Particle Boards, Resins and Chemicals).GVKBIO, providing an integrated platform of research services across the Pharma R&D & Contract Manufacturing value chain to a growing number of global Pharma and Biotech companies.The Company has ~ 1500 employees spread across facilities in Hyderabad, Chennai and Gur-gaon.

Spansules was established in the year 2000 and commenced commercial manufacturing of Pre-formulation Pharmaceuticals at Hyderabad. Today Spansules has a manufacturing facility within the premises of Pharmaceuticals hub of Hyderabad . The facility was equipped with sophisticated equipments like, fluidized bed coater, Extruders, Spheronisers etc.